we have been waiting for over four years. With that kind of leeway you would think that errors would ave been minimized.
Intercept loses over $9 a share its $150, AMZN, makes $1.25 a share price $600, BIIB makes $15 a share, price $275. and mind you they have only 200 million shares outstanding as opposed to Gilead having over a billion. So what is one to do??
don't you could probably make more money just selling covered call on FB. FB is loved and growing leaps and bounds, Baba has massive sales but too many questions. And this is from someone who owns more shares of Babba than FB.
approval will be granted.
calling it the most expensive drug in the country. I know that Amgen's drug that comes in at $250.000 a year and cures nothing is far more expensive. Plus they continue to say that the cure cost is $85.000 per patient, again not true. With the discount of 40% and more it basically comes in at the $36.000 price that pharmassett had originally quoted.
they call you up to tell you this?